Claxton, Ami J.

A systematic review of the associations between dose regimens and medication compliance

Claxton, A. J., Cramer, J., & Pierce, C. (2001) · Clinical Therapeutics

Medication Adherence and CompliancePharmacy and Medical Practices

Cited by 2,388

Attention-deficit/hyperactivity disorder: increased costs for patients and their families

SWENSEN, A. R., BIRNBAUM, H. G., SECNIK, K., MARYNCHENKO, M., GREENBERG, P., & CLAXTON, A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life

Cited by 189

Economic implications of treatment-resistant depression among employees

Greenberg, P., Corey-Lisle, P. K., Birnbaum, H., Marynchenko, M., & Claxton, A. (2004) · PharmacoEconomics

Treatment of Major DepressionMental Health Treatment and Access

Cited by 113

Identification of a Claims Data "Signature" and Economic Consequences for Treatment-Resistant Depression

Corey-Lisle, P. K., Birnbaum, H. G., Greenberg, P. E., Marynchenko, M. B., & Claxton, A. J. (2002) · The Journal of Clinical Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 84

Selective serotonin reuptake inhibitor treatment in the UK: Risk of relapse or recurrence of depression

Claxton, A. J., Li, Z., & McKendrick, J. (2000) · British Journal of Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 68